SOX10 and central nervous system cancer: Also, although analysis of TCGA dataset revealed a significant correlation of higher SOX10 expression with the reduced overall survival (3 and 5 years) of glioma patients, and the median survival for patients with high SOX10 expression was shorter than that for patients with low SOX10 expression, other in silico validation about circEPHB4 and miR‐637 from public data is needed.